Avidian Wealth Enterprises’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $825K | Buy |
11,947
+947
| +9% | +$65.4K | 0.03% | 231 |
|
|
2025
Q1 | $764K | Buy |
11,000
+1,206
| +12% | +$83.7K | 0.03% | 230 |
|
|
2024
Q4 | $842K | Sell |
9,794
-209
| -2% | -$18K | 0.04% | 214 |
|
|
2024
Q3 | $1.19M | Sell |
10,003
-151
| -1% | -$18K | 0.05% | 162 |
|
|
2024
Q2 | $1.45M | Buy |
10,154
+268
| +3% | +$38.3K | 0.06% | 144 |
|
|
2024
Q1 | $1.27M | Buy |
9,886
+2,021
| +26% | +$259K | 0.06% | 134 |
|
|
2023
Q4 | $814K | Buy |
7,865
+474
| +6% | +$49K | 0.05% | 185 |
|
|
2023
Q3 | $672K | Sell |
7,391
-8,231
| -53% | -$749K | 0.05% | 205 |
|
|
2023
Q2 | $1.26M | Sell |
15,622
-2,030
| -12% | -$164K | 0.08% | 152 |
|
|
2023
Q1 | $1.4M | Sell |
17,652
-2,768
| -14% | -$220K | 0.08% | 163 |
|
|
2022
Q4 | $1.38M | Buy |
20,420
+474
| +2% | +$32.1K | 0.09% | 140 |
|
|
2022
Q3 | $994K | Buy |
19,946
+1,624
| +9% | +$80.9K | 0.07% | 148 |
|
|
2022
Q2 | $1.02M | Buy |
18,322
+508
| +3% | +$28.3K | 0.07% | 163 |
|
|
2022
Q1 | $989K | Buy |
17,814
+3,442
| +24% | +$191K | 0.06% | 191 |
|
|
2021
Q4 | $805K | Sell |
14,372
-490
| -3% | -$27.4K | 0.05% | 218 |
|
|
2021
Q3 | $713K | Sell |
14,862
-1,410
| -9% | -$67.6K | 0.05% | 166 |
|
|
2021
Q2 | $682K | Buy |
16,272
+2,528
| +18% | +$106K | 0.05% | 169 |
|
|
2021
Q1 | $463K | Buy |
13,744
+1,508
| +12% | +$50.8K | 0.04% | 221 |
|
|
2020
Q4 | $427K | Buy |
+12,236
| New | +$427K | 0.04% | 207 |
|